The Diagnosis and Treatment of Fibromuscular Dysplasia: An Update for Cardiologists
Fibromuscular dysplasia (FMD) is an arteriopathy of unknown etiology which has traditionally been associated with secondary hypertension; however, it has garnered increased attention in the cardiology field in the recent years because of its potential association with spontaneous coronary artery dissection. Cardiologists should be aware that FMD is a polyvascular disease which can affect any arterial bed and can result in morbid conditions such as chronic headaches, pulsatile tinnitus, stroke from cervical artery dissection, and renal infarction from renal artery dissection and has also been associated with increased prevalence of arterial aneurysm, including brain aneurysm. For these reasons, some experts recommend panvascular imaging from head-to-pelvis upon diagnosis for screening purposes and targeted imaging surveillance after diagnosis. When necessary, endovascular intervention with angioplasty alone is the preferred modality, though there are still situations which require surgical intervention. Patients with FMD may benefit from a multispecialty team approach for optimal treatment.
KeywordsFibromuscular dysplasia Vascular disease
Compliance with Ethical Standards
Conflict of Interest
Esther S. H. Kim is a consultant for Philips Ultrasound.
Maya Serhal declares no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as:••Of major importance
- 1.••Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–78. Class IV - This provides a thorough review of the history, clinical presentation, and management of FMD.CrossRefPubMedGoogle Scholar
- 2.••Olin JW, Froehlich J, Gu X, et al. The United States registry for fibromuscular dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90. Class III - This publication lays the groundwork for a large degree of what we currently know about the clinical presentation of FMD. It was the first large scale assessment of patients with FMD and has shed light on the clinical presentation of these patients.CrossRefPubMedGoogle Scholar
- 4.••Saw J, Ricci D, Starovoytov A, Fox R, Buller CE. Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. J Am Coll Cardiol Intv. 2013;6(1):44–52. Class III - Investigators help better characterize patients that are affected by SCAD and in turn, help recognize SCAD to the right patient population.CrossRefGoogle Scholar
- 5.Leadbetter W, Burkland CE. Hypertension in unilateral renal disease. J Urol. 1938;39(61):1–626.Google Scholar
- 11.Kadian-Dodov D, Gornik H, Gu X, et al. Aneurysm and dissection in fibromuscular dysplasia: findings from the united states registry for FMD. J Am Coll Cardiol. 2014;63(12_S). doi: 10.1016/S0735-1097(14)62033-7.
- 12.••Kim ES, Olin JW, Froehlich JB, et al. Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the united states registry for fibromuscular dysplasia. J Am Coll Cardiol. 2013;62(21):2026–8. Class III -Investigators delineate the differences in presentation between men and women in FMD.CrossRefPubMedGoogle Scholar
- 14.••Tweet MS, Hayes SN, Pitta SR, et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012;126(5):579–88. Class III - Investigators reviewed the clinical presentation of patients with SCAD and the differences of in the outcomes with different management strategies.CrossRefPubMedGoogle Scholar
- 23.Gowda MS, Loeb AL, Crouse LJ, Kramer PH. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the “gold standard”? J Am Coll Cardiol. 2003;41(8):1305–11.CrossRefPubMedGoogle Scholar
- 24.••Persu A, Giavarini A, Touze E, et al. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens. 2014;32(7):1367–78. Class IV - This provides a concise review of the new findings in FMD and helps guide management, with insight into appropriate imaging and insight with regards to which patients should undergo intervention.CrossRefPubMedGoogle Scholar
- 25.Quirk K, Bandyk DF. Interpretation of carotid duplex testing. Semin Vasc Surg. 2013;26(2):72-85. doi: 10.1053/j.semvascsurg.2014.01.003.
- 41.Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. The Cochrane database of systematic reviews. 2010:CD000255.Google Scholar
- 46.Dennison-Himmelfarb C, Handler J, Lackland DT, et al. 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth joint national committee (JNC 8). 2013.Google Scholar
- 47.Stone NJ, Merz CNB, ScM F, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. 2013.Google Scholar
- 49.Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the american association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the american association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; TransAtlantic inter-society consensus; and vascular disease foundation. Circulation. 2006;113(11):e463–654.CrossRefPubMedGoogle Scholar
- 57.Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RS. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the international subarachnoid aneurysm trial (ISAT). Lancet. 2015;385(9969):691–7.CrossRefPubMedPubMedCentralGoogle Scholar
- 58.Komotar RJ, Mocco J, Solomon RA. Guidelines for the surgical treatment of unruptured intracranial aneurysms: the First Annual J. Lawrence Pool Memorial Research Symposium—controversies in the management of cerebral aneurysms. Neurosurgery. 2008;62(1):183–93. discussion 193-4.CrossRefPubMedGoogle Scholar
- 60.Stanley JC, Henke P. Renal artery bypass. In: Lumley JS, Hoballab JJ, editors. Vascular Surgery: Springer Surgery Atlas Series. Berlin, Germany: Springer-Verlag; 2009. p. 241–56.Google Scholar